|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 220.7 ZAR | +1.98% |
|
+1.70% | +8.46% |
| Mar. 08 | Aspen Pharmacare Holdings Limited Announces Board Changes | CI |
| Mar. 05 | Aspen Pharmacare Holdings Limited Seeks Acquisitions | CI |
JOHANNESBURG (Reuters) - Aspen Pharmacare will buy the Chinese business of Swiss group Sandoz, including commercialisation rights and intellectual property for some established products and those in the pipeline, for up to 92.6 million euros ($100.6 million), the South African company said on Monday.
Aspen Global Incorporated, a subsidiary of Aspen, will also dispose of the commercialisation rights and related intellectual property for four anaesthetic products currently sold by Aspen in the European Economic Area.
($1 = 0.9205 euros)
(Reporting by Nqobile Dludla; Editing by David Goodman)
Price
|
Change
|
5d. change
|
Capi.
| ||
|---|---|---|---|---|---|
| 1,962 PTS | +1.81% | +2.47% | - | ||
| 462 PTS | +1.81% | +1.69% | - | ||
| 220.7 ZAR | +1.98% | +1.70% | 5.22B | ||
| 157.6 PTS | +3.21% | +3.26% | - | ||
| 30 CHF | -2.31% | +1.66% | 14.09B | ||
| 1st Jan change | Capi. | |
|---|---|---|
| +8.46% | 5.22B | |
| +19.62% | 43.34B | |
| +20.44% | 21.96B | |
| +10.86% | 14.09B | |
| +13.07% | 13.64B | |
| +37.46% | 11.43B | |
| -8.59% | 6.86B | |
| -0.05% | 6.79B | |
| -8.87% | 5.73B | |
| -4.29% | 4.71B |
ASPEN PHARMACARE HOLDINGS LIMITED 
